ES2097277T3 - Uso de un compuesto ester tiol-s-(2-dietilaminoetilico) para la preparacion de un medicamento para el tratamiento de la incontinencia neuro-muscular. - Google Patents

Uso de un compuesto ester tiol-s-(2-dietilaminoetilico) para la preparacion de un medicamento para el tratamiento de la incontinencia neuro-muscular.

Info

Publication number
ES2097277T3
ES2097277T3 ES92302204T ES92302204T ES2097277T3 ES 2097277 T3 ES2097277 T3 ES 2097277T3 ES 92302204 T ES92302204 T ES 92302204T ES 92302204 T ES92302204 T ES 92302204T ES 2097277 T3 ES2097277 T3 ES 2097277T3
Authority
ES
Spain
Prior art keywords
ester
neuro
incontinence
muscular
diethylaminoethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92302204T
Other languages
English (en)
Inventor
William M Davis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
United Pharmaceuticals Inc
Original Assignee
United Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by United Pharmaceuticals Inc filed Critical United Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2097277T3 publication Critical patent/ES2097277T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/265—Esters, e.g. nitroglycerine, selenocyanates of carbonic, thiocarbonic, or thiocarboxylic acids, e.g. thioacetic acid, xanthogenic acid, trithiocarbonic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Meat, Egg Or Seafood Products (AREA)

Abstract

UN COMPUESTO TIOL PARA USO EN EL TRATAMIENTO DE INCONTINENCIA NEUROMUSCULAR CARACTERIZADO POR QUE EL COMPUESTO SE SELECCIONA DE: TRIMETILACETIL 1 OIL ENZOIL TIO
ES92302204T 1991-11-15 1992-03-13 Uso de un compuesto ester tiol-s-(2-dietilaminoetilico) para la preparacion de un medicamento para el tratamiento de la incontinencia neuro-muscular. Expired - Lifetime ES2097277T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/792,799 US5130336A (en) 1991-11-15 1991-11-15 Method for treatment for neuro-muscular incontinence

Publications (1)

Publication Number Publication Date
ES2097277T3 true ES2097277T3 (es) 1997-04-01

Family

ID=25158104

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92302204T Expired - Lifetime ES2097277T3 (es) 1991-11-15 1992-03-13 Uso de un compuesto ester tiol-s-(2-dietilaminoetilico) para la preparacion de un medicamento para el tratamiento de la incontinencia neuro-muscular.

Country Status (8)

Country Link
US (1) US5130336A (es)
EP (1) EP0542392B1 (es)
JP (1) JPH05194210A (es)
AT (1) ATE145133T1 (es)
AU (1) AU656174B2 (es)
CA (1) CA2066983A1 (es)
DE (1) DE69215191T2 (es)
ES (1) ES2097277T3 (es)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4432977A (en) * 1982-08-27 1984-02-21 William P. Poythress & Company Method for dilating the smooth muscles of the upper urinary tract
AU558862B2 (en) * 1983-04-14 1987-02-12 United Pharmaceuticals Inc. Di-n-substituted aminoethyl ester of diphenyl thioacetic acid
US4652649A (en) * 1985-02-20 1987-03-24 United Pharmaceuticals, Inc. Anti-spasmodic agents having a ring in the main chain
US4725593A (en) * 1985-02-20 1988-02-16 United Pharmaceuticals, Inc. Method of treating smooth muscle spasm

Also Published As

Publication number Publication date
AU1282592A (en) 1993-05-20
EP0542392A1 (en) 1993-05-19
DE69215191D1 (de) 1996-12-19
DE69215191T2 (de) 1997-06-12
US5130336A (en) 1992-07-14
ATE145133T1 (de) 1996-11-15
CA2066983A1 (en) 1993-05-16
JPH05194210A (ja) 1993-08-03
AU656174B2 (en) 1995-01-27
EP0542392B1 (en) 1996-11-13

Similar Documents

Publication Publication Date Title
TW249226B (es)
NL300174I1 (nl) Toepassing van venlafaxine of een aryloxypropaanamineverbinding voor de bereiding van een geneesmiddel voor de behandeling van incontinentie.
PL298146A1 (en) Biologically active mixture
EP0497258A3 (en) Use of adenosine antagonists in the prevention and treatment of pancreatitis and ulcer
ES2096867T3 (es) Uso de antagonistas competitivos del receptor de nmda en el tratamiento de la incontinencia urinaria.
EP0781561A4 (en) NEW MEDICAL USE OF A 5HT 3 ANTAGONIST?
EP0550006A3 (en) Use of n-acyl derivatives of aminoalcohols for the manufacture of a medicament for the treatment of pathologies involving mast cells
ES2093774T3 (es) Estimulacion de la curacion de heridas con un compuesto 15-cetoprostaglandina.
EP0455448A3 (en) Treatment of pancreatic disease with 15-keto-prostaglandin compounds
DK0501705T3 (da) Anvendelse af tomoxetin til behandling af sygdomme i de nedre urinveje
FI924744A0 (fi) Terapeutiska aemnen
EP0467564A3 (en) Treatment of inflammatory diseases with 15-keto-prostaglandin compounds
AU7777794A (en) Melatonin derivatives for use in treating sleep disorders
DK0458589T3 (da) Behandling af okulær hypertension med en okulær synergistisk kombination
GR3018651T3 (en) Treatment of ocular hypertention with a synergistic combination
ES2097277T3 (es) Uso de un compuesto ester tiol-s-(2-dietilaminoetilico) para la preparacion de un medicamento para el tratamiento de la incontinencia neuro-muscular.
DE69100171D1 (de) Synergistische kombination zur ophthalmischen verwendung.
ES2129401T3 (es) Uso de un compuesto terapeutico para el tratamiento de bronquitis.
CA2188871A1 (en) Method for Treating Psoriasis
ES2124926T3 (es) Uso de desoxipergualina para la preparacion de un medicamento para el tratamiento de enfermedades inflamatorias e hiperreactivas.
EP0607774A3 (es)
ES2173550T3 (es) Uso de olanzapina para la fabricacion de un medicamento para la neuroproteccion.
MX9706825A (es) El uso farmacologico de ciertos derivados de cistina.
DK0779075T3 (da) Anvendelse af 3-alpha-hydroxy-5-alpha-androsta-16-en som lægemidler
DE69434010D1 (de) C7-Taxan-Derivate und diese enthaltende pharmazeutische Zusammenstellungen

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 542392

Country of ref document: ES